794 related articles for article (PubMed ID: 2580438)
21. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
[TBL] [Abstract][Full Text] [Related]
22. First-trimester serum levels of the beta-subunit of human chorionic gonadotropin in a tubal molar pregnancy.
Chase JS; Check JH; Nowroozi K; Wu CH
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):910. PubMed ID: 2445209
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
24. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
25. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
Yuen BH; Cannon W; Benedet JL; Boyes DA
Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
[TBL] [Abstract][Full Text] [Related]
26. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
27. [Influence of human chorionic gonadotropin (hCG) in combination with a 500 calorie diet on clinical and laboratory parameters in premenopausal women with and without hormonal contraception].
Rabe T; Richter S; Kiesel L; Zaloumis M; Runnebaum B
Aktuel Endokrinol Stoffwechsel; 1987 Jul; 8(3):142-9. PubMed ID: 12281505
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
29. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
[TBL] [Abstract][Full Text] [Related]
30. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
31. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
[TBL] [Abstract][Full Text] [Related]
32. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
33. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
34. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
[TBL] [Abstract][Full Text] [Related]
35. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
[TBL] [Abstract][Full Text] [Related]
36. Neoplasia and hormonal contraception.
Huggins GR
Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
[TBL] [Abstract][Full Text] [Related]
37. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
38. Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy.
Gockley AA; Lin LH; Davis M; Melamed A; Rizzo A; Sun SY; Elias K; Goldstein DP; Berkowitz RS; Horowitz NS
Clinics (Sao Paulo); 2021; 76():e2830. PubMed ID: 34468539
[TBL] [Abstract][Full Text] [Related]
39. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
[TBL] [Abstract][Full Text] [Related]
40. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
Tangtakul S; Srisupundit S
J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
